Stay updated on XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe history page now shows Revision: v3.5.4, signaling a newer release of the interface. This update reflects a system or UI upgrade rather than adjustments to the underlying study records.SummaryDifference0.1%

- Check20 days agoChange DetectedA new version entry dated 2026-05-05 appears with a Study Status change (version 12), and the previous entry dated 2025-07-17 is deleted from the history.SummaryDifference0.4%

- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s footer revision indicator is updated from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov software release/version change rather than a change to the trial record itself.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision v3.5.2 was added to the history and Revision v3.5.0 was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision v3.5.0 was added to the record history and revision v3.4.3 was deleted.SummaryDifference0.1%

- Check78 days agoChange DetectedThe Record History shows an added revision entry for v3.4.3 and a removed entry for v3.4.2.SummaryDifference0.1%

Stay in the know with updates to XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.